Video | Roundtable on Clinical Trials for Essential Thrombocythemia (ET) Patients in the USA

On June 25th, 2025, the Global MPN Scientific Foundation hosted a meaningful roundtable focused on Essential Thrombocythemia (ET) for patients and caregivers in the USA.

This virtual session featured an insightful intervention by Prof. Hugh Rienhoff, a renowned expert in genetics, medicine, and MPN innovation, who introduced the foundations of clinical trials and discussed the development of a new trial for ET currently underway.

Participants also heard directly from ET patients, who openly shared their experiences, perspectives, and hopes for the future, highlighting the importance of community, collaboration, and access to innovation.

Watch the video

The first part of the roundtable is now available and offers an excellent overview of how clinical trials work and why patient involvement is essential. 

To watch the full session, access it exclusively on our patient platform MPN World.

If you are not a patient but would like to view the content, you may contact us at info@gmpnsf.org, and we’ll be happy to share the video directly.

At the Global MPN Scientific Foundation, we are committed to strengthening the collaboration among Patients, Physicians, and Pharma—the 3P’s to move forward together.